ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
ACVR1 |
Q04771
|
activin A receptor type 1
|
Kinase
|
0.33 |
0.535 |
0.731 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
ATR |
Q13535
|
ATR serine/threonine kinase
|
Kinase
|
3.5E-09 |
0.456 |
0.923 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
BCS1L |
Q9Y276
|
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
|
|
4.7E-13 |
0.534 |
0.808 |
BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
CALR |
P27797
|
calreticulin
|
Calcium-binding protein
|
0.89 |
0.413 |
0.923 |
CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
CCL3 |
P10147
|
C-C motif chemokine ligand 3
|
Signaling
|
0.35 |
0.460 |
0.885 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CD69 |
Q07108
|
CD69 molecule
|
|
3.0E-02 |
0.488 |
0.923 |
CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
CEBPA |
P49715
|
CCAAT enhancer binding protein alpha
|
Transcription factor
|
0.55 |
0.496 |
0.692 |
CHTOP |
Q9Y3Y2
|
chromatin target of PRMT1
|
Nucleic acid binding
|
0.76 |
0.722 |
0.346 |
CNTNAP1 |
P78357
|
contactin associated protein 1
|
|
3.4E-05 |
0.554 |
0.577 |
CNTRL |
Q7Z7A1
|
centriolin
|
|
1.9E-54 |
0.711 |
0.423 |